MedTrace Logo

Efficacy Study of Korean Red Ginseng to Treat Depression

NCT01496248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2014-10-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Korean Red Ginseng are effective in the treatment of the residual symptoms of depression as an adjuvant treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Korean Red Ginseng

100% of the past psychiatric medication dose will be maintained during 8 week study period. Korean Red ginseng will be started with 2g/day and then maintained using flexible dosing of 2-3g/day during the study period.

Sponsors & Collaborators

  • The Korean Society of Ginseng

    collaborator OTHER

  • Korea University

    lead OTHER

Principal Investigators

  • Young-Hoon Ko, M.D., Ph.D. · Korea University Medical Centre

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-07-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496248 on ClinicalTrials.gov